Free Trial

Adverum Biotechnologies (ADVM) Competitors

Adverum Biotechnologies logo
$2.38 +0.13 (+5.53%)
Closing price 07/3/2025 02:21 PM Eastern
Extended Trading
$2.33 -0.05 (-2.31%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADVM vs. CRGX, CYBN, EDIT, EPRX, ENGN, TLSA, CTMX, OGI, GNFT, and FDMT

Should you be buying Adverum Biotechnologies stock or one of its competitors? The main competitors of Adverum Biotechnologies include CARGO Therapeutics (CRGX), Cybin (CYBN), Editas Medicine (EDIT), Eupraxia Pharmaceuticals (EPRX), enGene (ENGN), Tiziana Life Sciences (TLSA), CytomX Therapeutics (CTMX), Organigram Global (OGI), GENFIT (GNFT), and 4D Molecular Therapeutics (FDMT). These companies are all part of the "pharmaceutical products" industry.

Adverum Biotechnologies vs. Its Competitors

Adverum Biotechnologies (NASDAQ:ADVM) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

CARGO Therapeutics' return on equity of -45.93% beat Adverum Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Adverum BiotechnologiesN/A -130.53% -66.31%
CARGO Therapeutics N/A -45.93%-39.58%

Adverum Biotechnologies presently has a consensus target price of $23.80, indicating a potential upside of 897.90%. CARGO Therapeutics has a consensus target price of $15.00, indicating a potential upside of 235.57%. Given Adverum Biotechnologies' stronger consensus rating and higher probable upside, analysts clearly believe Adverum Biotechnologies is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adverum Biotechnologies
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

Adverum Biotechnologies has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adverum Biotechnologies$1M49.82-$130.93M-$6.40-0.37
CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97

In the previous week, Adverum Biotechnologies had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 2 mentions for Adverum Biotechnologies and 0 mentions for CARGO Therapeutics. Adverum Biotechnologies' average media sentiment score of 0.00 equaled CARGO Therapeutics'average media sentiment score.

Company Overall Sentiment
Adverum Biotechnologies Neutral
CARGO Therapeutics Neutral

48.2% of Adverum Biotechnologies shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 6.0% of Adverum Biotechnologies shares are owned by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Adverum Biotechnologies has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500.

Summary

Adverum Biotechnologies beats CARGO Therapeutics on 9 of the 13 factors compared between the two stocks.

Get Adverum Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADVM vs. The Competition

MetricAdverum BiotechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$49.82M$2.89B$5.53B$9.02B
Dividend YieldN/A2.44%5.22%3.99%
P/E Ratio-0.3721.7127.7920.25
Price / Sales49.82283.26426.06119.26
Price / CashN/A41.7026.2128.59
Price / Book0.707.538.045.65
Net Income-$130.93M-$55.14M$3.18B$249.15M
7 Day Performance10.93%4.22%2.89%2.91%
1 Month Performance-15.72%0.91%1.67%4.11%
1 Year Performance-65.38%5.40%34.53%20.98%

Adverum Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADVM
Adverum Biotechnologies
4.0895 of 5 stars
$2.39
+5.5%
$23.80
+897.9%
-65.4%$49.82M$1M-0.37190
CRGX
CARGO Therapeutics
1.4841 of 5 stars
$4.12
-1.7%
$15.00
+264.1%
-70.9%$193.20MN/A-0.89116Positive News
CYBN
Cybin
3.1342 of 5 stars
$8.39
+2.9%
$86.00
+925.0%
N/A$193.17MN/A-1.9250Analyst Revision
EDIT
Editas Medicine
4.191 of 5 stars
$2.20
-3.5%
$4.70
+113.6%
-43.7%$190.87M$32.31M-0.72230
EPRX
Eupraxia Pharmaceuticals
2.4598 of 5 stars
$5.76
+8.7%
$11.00
+91.0%
+117.3%$190.57MN/A-7.5829Gap Up
High Trading Volume
ENGN
enGene
2.774 of 5 stars
$3.64
-0.5%
$23.29
+539.7%
-57.6%$187.04MN/A-2.2131
TLSA
Tiziana Life Sciences
0.6693 of 5 stars
$1.58
-1.3%
N/A+85.5%$186.96MN/A0.008Positive News
CTMX
CytomX Therapeutics
3.8437 of 5 stars
$2.27
+0.9%
$5.33
+134.9%
+93.0%$181.40M$138.10M4.73170
OGI
Organigram Global
0.5318 of 5 stars
$1.35
flat
N/A-10.4%$180.82M$117.47M13.50860
GNFT
GENFIT
1.9744 of 5 stars
$3.73
+3.2%
$13.00
+249.0%
-8.2%$180.49M$67.00M0.00120Positive News
Gap Up
FDMT
4D Molecular Therapeutics
2.2729 of 5 stars
$3.71
-3.4%
$29.56
+696.6%
-80.6%$177.89M$40K-1.17120

Related Companies and Tools


This page (NASDAQ:ADVM) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners